Shares of Krsnaa Diagnostics jumped as much as 11.48% during Thursday’s trading session, touching an intraday high of Rs 598, after the company announced the execution of a 15-year concession agreement with Punjab Health Systems Corporation (PHSC).
The agreement marks Krsnaa Diagnostics’ entry into the PET-CT diagnostic services segment, opening up a new avenue of growth for the company amid rising demand for advanced oncology diagnostics.